Details for New Drug Application (NDA): 209421
✉ Email this page to a colleague
The generic ingredient in OSELTAMIVIR PHOSPHATE is oseltamivir phosphate. There are eight drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.
Summary for 209421
| Tradename: | OSELTAMIVIR PHOSPHATE |
| Applicant: | Strides Pharma |
| Ingredient: | oseltamivir phosphate |
| Patents: | 0 |
Pharmacology for NDA: 209421
| Mechanism of Action | Neuraminidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 209421
Suppliers and Packaging for NDA: 209421
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 209421 | ANDA | A-S Medication Solutions | 50090-6239 | 50090-6239-0 | 10 CAPSULE in 1 BLISTER PACK (50090-6239-0) |
| OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 209421 | ANDA | Strides Pharma Science Limited | 64380-797 | 64380-797-01 | 10 CAPSULE in 1 BLISTER PACK (64380-797-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 30MG BASE | ||||
| Approval Date: | Jun 8, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 45MG BASE | ||||
| Approval Date: | Jun 8, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 75MG BASE | ||||
| Approval Date: | Jun 8, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
